Isomorphic Labs' $5B AI Drug Bet: Cures by Computer
🧬 Google's AI Just Raised $5 Billion to Design Your Next Medicine Co-produced by Daniel Aharonoff and DigitalDan As the chief editor of mindburst.ai, I have covered a lot of big AI funding rounds. I have seen chip companies raise billions, chatbot startups chase trillion-dollar valuations, and data center deals that read like the GDP of a small country. But today's news stopped me in my tracks, because it is not about faster chatbots or cheaper GPUs. It is about something much more personal: the medicine you might take one day. Isomorphic Labs, the AI drug discovery company spun out of Google DeepMind, just raised $5 billion in a Series C funding round. Five. Billion. Dollars. For a company whose entire job is letting artificial intelligence design new drugs. And if that sounds like science fiction, buckle up — because the science fiction part is already happening. So what's the big deal? The dollar figure is only half the story. The other half is what it tells u...